{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:57:27Z","timestamp":1779879447403,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jhin.2025.11.005","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:48:16Z","timestamp":1763650096000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Is mandatory surveillance of carbapenemase-producing Gram-negative organisms working? A surveillance evaluation, England, 2020\u20132023"],"prefix":"10.1016","volume":"169","author":[{"given":"L.","family":"Findlater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 7","key":"10.1016\/j.jhin.2025.11.005_bib1","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2025.11.005_bib2","series-title":"Carbapenemase-producing Gram-negative organisms in England since October 2020: quarterly update, Q4 2024","year":"2025"},{"issue":"6","key":"10.1016\/j.jhin.2025.11.005_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11061491","article-title":"A review of carbapenem resistance in Enterobacterales and its detection techniques","volume":"11","author":"Caliskan-Aydogan","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.jhin.2025.11.005_bib4","article-title":"The current burden of Carbapenemases: review of significant properties and dissemination among gram-negative bacteria","volume":"9","author":"Hammoudi Halat","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"10.1016\/j.jhin.2025.11.005_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jhin.2025.11.005_bib6","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jac\/dku084","article-title":"NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases","volume":"69","author":"Jain","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jhin.2025.11.005_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijantimicag.2013.08.020","article-title":"Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK","volume":"42","author":"Thomas","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2025.11.005_bib10","series-title":"English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report 2023 to 2024","year":"2024"},{"key":"10.1016\/j.jhin.2025.11.005_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.823684","article-title":"Global threat of carbapenem-resistant Gram-Negative Bacteria","volume":"12","author":"Jean","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhin.2025.11.005_bib12","series-title":"UK standards for microbiology investigations: detection of bacteria with carbapenem-hydrolysing \u03b2-lactamases (carbapenemases)","year":"2022"},{"key":"10.1016\/j.jhin.2025.11.005_bib14","series-title":"Contained and controlled: the UK\u2019s 20-year vision for antimicrobial resistance","year":"2019"},{"key":"10.1016\/j.jhin.2025.11.005_bib15","series-title":"Tackling antimicrobial resistance 2019\u20132024: The UK\u2019s five-year national action plan","year":"2019"},{"key":"10.1016\/j.jhin.2025.11.005_bib16","series-title":"The health protection (Notification) regulations 2010","year":"2010"},{"key":"10.1016\/j.jhin.2025.11.005_bib17","series-title":"Explanatory memorandum to the health protection (Notification) (Amendment) (No. 2) regulations 2020 No. 674","year":"2020"},{"issue":"10","key":"10.1016\/j.jhin.2025.11.005_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cmi.2016.07.020","article-title":"Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts","volume":"22","author":"Freeman","year":"2016","journal-title":"Clin Microbiol Inf"},{"issue":"1","key":"10.1016\/j.jhin.2025.11.005_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhin.2019.01.005","article-title":"An evaluation of the electronic reporting system for the enhanced surveillance of carbapenemase-producing Gram-negative bacteria in England","volume":"102","author":"Jermacane","year":"2019","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.jhin.2025.11.005_bib20","article-title":"Epidemiology of carbapenemase-producing Enterobacterales in England, May 2015-March 2019: national enhanced surveillance findings and approach","volume":"2","author":"Freeman","year":"2020","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.jhin.2025.11.005_bib21","series-title":"Framework of actions to contain carbapenemase-producing Enterobacterales","year":"2022"},{"key":"10.1016\/j.jhin.2025.11.005_bib22","series-title":"Data quality monitoring and surveillance system evaluation: A handbook of methods and applications","year":"2014"},{"issue":"4","key":"10.1016\/j.jhin.2025.11.005_bib23","article-title":"Understanding the landscape of carbapenemase-producing organisms (CPOs), and spotlighting opportunities for control in England","volume":"7","author":"Otu","year":"2025","journal-title":"Inf Prevent Pract"},{"issue":"12","key":"10.1016\/j.jhin.2025.11.005_bib24","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/cid\/cix615","article-title":"The impact of a carbapenem-resistant Enterobacteriaceae outbreak on facilitating development of a National Infrastructure for Infection Control in Israel","volume":"65","author":"Schwaber","year":"2017","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.jhin.2025.11.005_bib25","series-title":"Carbapenemase-Producing Organisms (CPO)","year":"2023"},{"key":"10.1016\/j.jhin.2025.11.005_bib26","series-title":"Carbapenem-resistant Enterobacterales (CRE): An urgent public health threat","year":"2021"},{"issue":"7\u20138","key":"10.1016\/j.jhin.2025.11.005_bib27","first-page":"308","article-title":"Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016-2020","volume":"48","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.jhin.2025.11.005_bib28","series-title":"Recommendations for the control of carbapenemase-producing Enterobacterales","year":"2021"},{"issue":"9","key":"10.1016\/j.jhin.2025.11.005_bib29","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018","volume":"24","author":"Brolund","year":"2019","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.jhin.2025.11.005_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/QCO.0000000000000608","article-title":"Epidemiology of carbapenem-resistant Gram-negative infections globally","volume":"32","author":"Brink","year":"2019","journal-title":"Curr Opin Inf Dis"},{"issue":"4","key":"10.1016\/j.jhin.2025.11.005_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"issue":"suppl_1","key":"10.1016\/j.jhin.2025.11.005_bib33","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhin.2025.11.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2024.11.016","article-title":"Polymicrobial outbreak of carbapenemase producing Enterobacterales managed using universal admission and discharge screening and water-safe built environment","volume":"156","author":"Meda","year":"2025","journal-title":"J Hosp Infect"},{"issue":"4","key":"10.1016\/j.jhin.2025.11.005_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/17571774241239222","article-title":"Examining the impact and response to an outbreak of carbapenemase-producing Enterobacterales in a neonatal unit in the United Kingdom: An outbreak report","volume":"25","author":"Anil","year":"2024","journal-title":"J Infect Prev"},{"issue":"2","key":"10.1016\/j.jhin.2025.11.005_bib36","article-title":"Determining the impact of professional body recommendations on the screening of acquired carbapenemase-producing Enterobacterales in England","volume":"5","author":"Bennet","year":"2023","journal-title":"Infect Prev Pract"},{"issue":"Suppl 1","key":"10.1016\/j.jhin.2025.11.005_bib37","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jacamr\/dlab052","article-title":"Antibiotic resistance during and beyond COVID-19","volume":"3","author":"Livermore","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jhin.2025.11.005_bib38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12913-019-4492-4","article-title":"Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation","volume":"19","author":"Schneider","year":"2019","journal-title":"BMC Health Services Res"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125003615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125003615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:04:15Z","timestamp":1777525455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670125003615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0195670125003615"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2025.11.005","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is mandatory surveillance of carbapenemase-producing Gram-negative organisms working? A surveillance evaluation, England, 2020\u20132023","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2025.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}